• Magle Chemoswed Holding approved long-term incentive programmes for employees and board members at its extraordinary general meeting on November 3, 2026.
• The employee programme covers up to 23,267,671 warrants of series 2026/2030:1, implying approximately 13.04% dilution upon full exercise.
• The board programme comprises up to 15,511,781 warrants of series 2026/2030:2, implying approximately 9.09% dilution upon full exercise.
• Participants will acquire warrants at market value. Each warrant entitles the holder to subscribe for one new share at SEK 0.50.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Magle Chemoswed Holding AB published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.